−0.035CAD
−5.03 MCAD
148.98 KCAD
82.80 M
About KANE BIOTECH INC
Sector
CEO
Marc Edwards
Website
Headquarters
Winnipeg
Founded
2001
ISIN
CA4838092084
FIGI
BBG000PQRZG0
Kane Biotech, Inc. is a biotechnology company, which engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. It operates through Domestic and International geographical segments. The firm's trademarks include StrixNB, DispersinB, Aledex, bluestem, silkstem, coactiv+, and Kan. The company was founded in 2001 and is headquartered in Winnipeg, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of KNE is 0.135 CAD — it has increased by 3.85% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange KANE BIOTECH INC stocks are traded under the ticker KNE.
KNE stock is 8.00% volatile and has beta coefficient of 0.77. Check out the list of the most volatile stocks — is KANE BIOTECH INC there?
Yes, you can track KANE BIOTECH INC financials in yearly and quarterly reports right on TradingView.
KNE stock hasn't changed in a week, the month change is a 28.57% rise, over the last year KANE BIOTECH INC has showed a 12.50% increase.
KNE net income for the last quarter is −1.38 M CAD, while the quarter before that showed −872.54 K CAD of net income which accounts for −57.98% change. Track more KANE BIOTECH INC financial stats to get the full picture.
Today KANE BIOTECH INC has the market capitalization of 17.14 M, it has increased by 30.43% over the last week.
No, KNE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, KNE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KANE BIOTECH INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KANE BIOTECH INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KANE BIOTECH INC stock shows the buy signal. See more of KANE BIOTECH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KANE BIOTECH INC EBITDA is −3.12 M CAD, and current EBITDA margin is −2.41 K%. See more stats in KANE BIOTECH INC financial statements.